Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenyi Jin

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cell Regeneration (London, England)|January 24, 2019
Approaches for generation of anti-leukemia specific T cellsZhenyi Jin, Ling Xu, Yangqiu Li
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|August 21, 2018
[Research progress of details enhancement methods in medical images]Yu Wang, Zhenyi Jin, Yuanjun Wang
DNA and Cell Biology|January 14, 2014
Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host diseaseZhenyi Jin, Xiuli Wu, Shaohua Chen, et al.
Frontiers in Immunology|February 13, 2023
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancyXuan Jiang, Xiaofang Wu, Yuxi Xiao, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|March 10, 2017
[Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma]Qiang Luo, Zhenyi Jin, Shaohua Chen, et al.
Scientific Reports|August 29, 2023
Identification of immune infiltration-related biomarkers in carotid atherosclerotic plaquesKai Zheng, Wentao Yang, Shengxing Wang, et al.
Frontiers in Immunology|January 31, 2024
Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemiaWandi Wang, Xiaofang Wu, Jiamian Zheng, et al.
Immunotargets and Therapy|January 15, 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in CancerYuchen Li, Yinfeng Gu, Pengyue Yang, et al.
Frontiers in Immunology|February 28, 2022
High <i>TRGV 9</i> Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid LeukemiaXueting Kong, Jiamian Zheng, Xiaxin Liu, et al.
International Journal of Medical Sciences|June 21, 2024
Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemiaJunjie Chen, Qi Hou, Tao Chang, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cell Regeneration (London, England)|January 24, 2019
Approaches for generation of anti-leukemia specific T cellsZhenyi Jin, Ling Xu, Yangqiu Li
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|August 21, 2018
[Research progress of details enhancement methods in medical images]Yu Wang, Zhenyi Jin, Yuanjun Wang
DNA and Cell Biology|January 14, 2014
Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host diseaseZhenyi Jin, Xiuli Wu, Shaohua Chen, et al.
Frontiers in Immunology|February 13, 2023
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancyXuan Jiang, Xiaofang Wu, Yuxi Xiao, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|March 10, 2017
[Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma]Qiang Luo, Zhenyi Jin, Shaohua Chen, et al.
Scientific Reports|August 29, 2023
Identification of immune infiltration-related biomarkers in carotid atherosclerotic plaquesKai Zheng, Wentao Yang, Shengxing Wang, et al.
Frontiers in Immunology|January 31, 2024
Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemiaWandi Wang, Xiaofang Wu, Jiamian Zheng, et al.
Immunotargets and Therapy|January 15, 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in CancerYuchen Li, Yinfeng Gu, Pengyue Yang, et al.
Frontiers in Immunology|February 28, 2022
High <i>TRGV 9</i> Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid LeukemiaXueting Kong, Jiamian Zheng, Xiaxin Liu, et al.
International Journal of Medical Sciences|June 21, 2024
Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemiaJunjie Chen, Qi Hou, Tao Chang, et al.
Pageof 3